On demand webinar: From Research to Routine - developing and delivering
multiplexed protein mass spectrometry based tests of clinical utility
You have been chosen to receive this valuable information.
<http://www.chromatographyonline.com/>
Agilent Technologies | Trusted Answers

<http://www.agilent.com/>

On demand webinar: From Research to Routine - developing and delivering
multiplexed protein mass spectrometry based tests of clinical utility

<http://agilent.com/en/promotions/research-to-routine>

From Research to Routine - developing and delivering multiplexed protein
mass spectrometry based tests of clinical utility

Despite a few decades of proteomics research and the apparent discovery
of multiple protein biomarkers to support the diagnosis and treatment of
patients, the number of biomarkers that have been developed to the stage
of being used routinely in clinical practice is disappointingly low. In
this presentation we will discuss key aspects of experimental design and
implementation in order to maximize the chances of successful biomarker
identification, characterization and quantitation.

  	Register now

<http://agilent.com/en/promotions/research-to-routine> 	 

 

For Research Use Only. Not for use in diagnostic procedures.

 

This presentation will cover:

&bull Start at the end: identifying clinical need.

&bull Protein biomarker discovery.

&bull From candidate protein biomarkers to peptide MRM assays – advantages for
biomarker evaluation.

&bull Delivery of robust and routine peptide MRM assays – from sample
preparation to test report.

 

Presenter

Stephen Pennington, Ph.D. 	

Stephen Pennington, Ph.D.,

Professor of Proteomics, Founder, CEO and CSO Atturos Ltd. C/O UCD
Conway Institute University College Dublin

	

 

Agilent Home <http://www.agilent.com/>  |  About Agilent
<http://www.agilent.com/about>  |  Legal
<http://www.agilent.com/go/terms>  |  Subscriptions
<http://www.agilent.com/en-us/newsletters>

5301 Stevens Creek Blvd, Santa Clara CA 95051, USA

Agilent is committed to respecting and protecting your privacy. To view
the promises that we make to you regarding your personal information,
please view Agilent's privacy statement
<http://www.agilent.com/go/privacy>. For questions related to privacy,
please send your inquiry to privacy_advocate@agilent.com
<mailto:privacy_advocate@agilent.com>. If you prefer not to receive
promotional e-mails from Agilent in the future, you can unsubscribe
<http://www.agilent.com/cs/agilent/en-us/globaloptout/form> at any time.
You can also update
<http://www.agilent.com/en-us/contact-us/na-profileupdate> your e-mail
address, contact information, or interest profile to ensure you receive
the most relevant information.

		
Facebook <https://www.facebook.com/Agilent.Tech> 	  	Twitter
<http://twitter.com/agilent> 	  	LinkedIn
<https://www.linkedin.com/company/agilent-technologies> 	  	Youtube
<https://www.youtube.com/user/agilent/>

&copy Agilent Technologies, Inc. 2017

	

View this email in web
<http://www.chem.agilent.com/edm/2017/10/research_to_routine/Pages/webinar_eDM_cn.html>
or text
<http://www.chem.agilent.com/edm/2017/10/research_to_routine/Pages/clinical_research_cn.txt>


Message above is a paid advertisement. Content is provided by the
sponsor. You received this email because you are a customer of LCGC, a
UBM publication. You are on the mailing list as %%emailaddress%%
<http://creative.advanstar.com/lcgc/2018/Jan18/Webinar/%%emailaddress%%>.